POU6F2 Antibody (N-term) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P78424 |
---|---|
Clone Names | 101008213 |
Gene ID | 11281 |
---|---|
Other Names | POU domain, class 6, transcription factor 2, Retina-derived POU domain factor 1, RPF-1, POU6F2, RPF1 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | POU6F2 |
---|---|
Synonyms | RPF1 |
Function | Probable transcription factor likely to be involved in early steps in the differentiation of amacrine and ganglion cells. Recognizes and binds to the DNA sequence 5'-ATGCAAAT-3'. Isoform 1 does not bind DNA. |
Cellular Location | Nucleus. |
Tissue Location | Expressed only within the CNS, where its expression is restricted to the medical habenulla, to a dispersed population of neurons in the dorsal hypothalamus, and to subsets of ganglion and amacrine cells in the retina. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
This gene encodes a member of the POU protein familycharacterized by the presence of a bipartite DNA binding domain,consisting of a POU-specific domain and a homeodomain, separated bya variable polylinker. The DNA binding domain may bind to DNA asmonomers or as homo- and/or heterodimers, in a sequence-specificmanner. The POU family members are transcriptional regulators, manyof which are known to control cell type-specific differentiationpathways. This gene is a tumor suppressor involved in Wilms tumor(WT) predisposition. Alternatively spliced transcript variantsencoding distinct isoforms have been found for this gene.
References
Anney, R., et al. Hum. Mol. Genet. 19(20):4072-4082(2010)Rose, J.E., et al. Mol. Med. 16 (7-8), 247-253 (2010) :Joslyn, G., et al. Alcohol. Clin. Exp. Res. 34(5):800-812(2010)Di Renzo, F., et al. J. Pediatr. Hematol. Oncol. 28(12):791-797(2006)Perotti, D., et al. J. Pediatr. Hematol. Oncol. 27(10):521-525(2005)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.